Physician profile
Isabelle Abraham
NPI 1073393815
$1,665.59
in general payments reported to CMS, 2019-2025
22 companies · $1,666 in 2025
The $1,666 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,665.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $232.77 | 2025 | Cuvitru, Hyqvia, Takhzyro |
| Novartis Pharmaceuticals Corporation | $165.46 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $165.17 | 2025 | Dupixent |
| Genentech USA, INC. | $160.97 | 2025 | Xolair |
| Ars Pharmaceuticals Operations, INC. | $127.50 | 2025 | Neffy |
| Genzyme Corporation | $91.39 | 2025 | |
| Csl Behring | $79.77 | 2025 | Privigen, Hizentra |
| Azurity Pharmaceuticals, INC. | $78.70 | 2025 | Alvesco |
| Astrazeneca Pharmaceuticals LP | $64.26 | 2025 | Tezspire |
| Pharming Healthcare, INC. | $59.35 | 2025 | Ruconest |
| Pfizer INC. | $55.73 | 2025 | |
| Grifols USA, LLC | $54.35 | 2025 | Xembify |
| Organon LLC | $52.08 | 2025 | Vtama |
| Leo Pharma INC. | $48.44 | 2025 | Adbry, Anzupgo |
| Kedrion Biopharma, INC. | $45.39 | 2025 | Gammaked, Kedrab, Albuked |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $44.13 | 2025 | Tezspire |
| Optinose US, INC. | $34.85 | 2025 | |
| Lilly USA, LLC | $23.51 | 2025 | Ebglyss |
| Galderma Laboratories, L.P. | $22.00 | 2025 | Nemluvio |
| Blueprint Medicines Corporation | $21.97 | 2025 | Ayvakit |
| Octapharma USA, INC. | $20.38 | 2025 | Octagam Immune Globulin (Human) |
| Ionis Pharmaceuticals, INC. | $17.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabelle Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.